Granules Pharma completes USFDA PADE Inspection with zero observations EP News Bureau Aug 4, 2023 The inspection was conducted at Granules Pharmaceuticals from July 31, 2023 to August 03, 2023
Granules Pharmaceuticals receives ANDA approval for Amphetamine mixed salts from US FDA EP News Bureau Dec 31, 2021 The product is bioequivalent to the Reference Listed Drug (RLD) product Adderall of Teva Women’s Health Inc, and would be…
Granules India gets Health Canada nod to market arthritis tablets Press Trust of India Aug 31, 2021 The drug will be manufactured at the company's manufacturing facility located in Gagillapur, Hyderabad